![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Möhnle, Patrick; Humpe, Andreas; Boeck, Markus; Gruetzner, Stefanie; Hackstein, Holger; Offner, Robert und Hildebrandt, Martin
(2022):
Emergency Use of Convalescent Plasma: Perception of the Regulatory Framework from a Clinical Perspective.
In: Transfusion Medicine and Hemotherapy, Bd. 49, Nr. 2: S. 119-124
Multhoff, Gabriele; Seier, Sophie; Stangl, Stefan; Sievert, Wolfgang; Shevtsov, Maxim; Werner, Caroline; Pockley, A. Graham; Blankenstein, Christiane; Hildebrandt, Martin; Offner, Robert; Ahrens, Norbert; Kokowski, Konrad; Hautmann, Matthias; Roedel, Claus; Fietkau, Rainer; Lubgan, Dorota; Huber, Rudolf; Hautmann, Hubert; Duell, Thomas; Molls, Michael; Specht, Hanno; Haller, Bernhard; Devecka, Michal; Sauter, Andreas und Combs, Stephanie E.
(2020):
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
In: Clinical Cancer Research, Bd. 26, Nr. 20: S. 5368-5379
Specht, Hanno M.; Ahrens, Norbert; Blankenstein, Christiane; Duell, Thomas; Fietkau, Rainer; Gaipl, Udo S.; Günther, Christine; Gunther, Sophie; Habl, Gregor; Hautmann, Hubert; Hautmann, Matthias; Huber, Rudolf Maria; Molls, Michael; Offner, Robert; Rödel, Claus; Rödel, Franz; Schütz, Martin; Combs, Stephanie E. und Multhoff, Gabriele
(2015):
Heat shock protein 70 (Hsp70) peptide activated Natural Killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx) - from preclinical studies to a clinical phase II trial.
In: Frontiers in Immunology, Bd. 6, UNSP 162
[PDF, 812kB]